Oracle’s Major Moves in the Healthcare Industry

By Michael Awood

September 29, 2023

Oracle, an IT company, has been making recent waves within the healthcare space. In late 2021, Oracle announced its plans to acquire Cerner, a digital information systems provider whose software hospitals use. The deal concluded a year later, in 2022, which saw Oracle take a share of the healthcare market in the Electronic Health Record space. This is because of Cerner’s already established presence.

The US has had a strong focus on healthcare services. The HITECH Act introduced an important piece of healthcare legislation in 2009. With this act, the US looked to spend around $25 billion to expand the adoption of health information technologies (HIT). One of the main areas of this act was the promotion of EHRs. It introduced incentives for adoption – specifically “meaningful use” of the technology. With this move, the shift of HIT – and subsequently healthcare – looked at improving both patient and provider experience. Initially, they did not introduce any penalties, but since 2015, they have been imposing penalties if they show no meaningful use. Keeping this in mind, Oracle positions itself well to use its strong technology services through its cloud in the healthcare domain. It can do this by optimising previous areas of healthcare with its existing technologies or by creating new and better ones.

A few years on, we now see Oracle making larger steps into this space. Earlier this year, a collaboration began between Deloitte and Oracle – “Deloitte Health – Oracle Accelerated”. Deloitte aims to enhance healthcare delivery systems and continue their work in the healthcare field as part of the Oracle Partner Network.

Oracle showcased their most recent move at their Oracle Health Conference. They announced the further integration and optimisation of their cloud services into the EHR space by leveraging generative AI. This looks to improve patient experience and decrease the administrative burden on the providers. They specifically spoke about how this should rather add value to services while “eliminating redundant processes“. The Clinical Digital Assistant is going to do exactly that. Being multimodal in its design, it’s able to read notes, take voice commands from providers and is context-aware. It provides the patients with crucial reminders of their appointments and can answer questions about their treatment regimes.

The outcome of this assistant also looks at personalising the care pathway and experience. This is an understated area of healthcare as it purely looked at the standard model of treating the problem. Providing information to the patient, and guiding them through what could be a difficult journey, ensures a higher efficiency in value creation. Wide adoption of the tools has been prioritised as Oracle ensured that the services could be added on in a modular fashion without having to implement large system changes. It is expected that these tools roll out over the next few months.

Cover image taken from the Oracle Health Conference Keynote. Watch it here

 

Reference url

Recent Posts

EU Life Sciences Strategy
         

EU Life Sciences Strategy: Paving the Way for Europe’s Leadership by 2030

🚀 Is Europe poised to reclaim its leadership in life sciences by 2030?

The European Commission has unveiled a game-changing strategy aimed at transforming the EU into the world’s leading hub for life sciences, tackling critical challenges in health, biotechnology, and sustainability. With strategic investments and reforms, this initiative promises to bridge the innovation gap and enhance public health outcomes across the continent.

Curious about how these plans will impact the life sciences landscape? Explore the full insights of this exciting strategy!

#SyenzaNews #HealthcareInnovation #DigitalTransformation #Innovation

ticagrelor data integrity
          

Ticagrelor Data Integrity Under Fire: Scrutiny Reveals Flaws in Key Clinical Trials

🔍 Are we truly getting the full story on high-cost medications like ticagrelor?

A recent BMJ investigation has raised alarm bells over the integrity of data from pivotal studies on AstraZeneca’s ticagrelor, revealing significant misreporting and missing data that may undermine its clinical benefits. This exposes critical implications for health economics, regulatory oversight, and market access.

Curious about how these findings could reshape perceptions of drug efficacy and safety? Dive into the full article to uncover the truth behind the numbers.

#SyenzaNews #HealthEconomics #Pharmaceuticals #MarketAccess

self-care public health
    

The Value of Self-Care in Public Health: Insights and Implications for Europe

🌍 Are we overlooking the power of self-care in Europe’s public health strategy?

The rise of self-care public health is reshaping how minor ailments are managed across the continent, leading to remarkable economic and productivity benefits. With annual savings of €36 billion and lifestyle improvements for consumers, self-care is proving to be a game-changer for healthcare systems.

Explore how embracing self-care can alleviate pressure on healthcare providers and enhance individual well-being. Dive into the full article to discover the implications for health economics and public policy!

#SyenzaNews #HealthEconomics #HealthcarePolicy

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

JOIN NEWSLETTER

© 2025 Syenza™. All rights reserved.